Long Covid Newsletter
Issue #15December 15, 20257 studies

Long COVID linked to persistent inflammation and autonomic dysfunction

New research is painting a clearer picture of what's happening inside the bodies of people with long COVID—and it's revealing some surprising patterns that could change how we think about treating this condition.

🔥 Persistent inflammation found in long COVID patients 180+ days after infection

  • 142 individuals were studied between 2020-2021, including 28 patients with long COVID and 24 recovered controls

  • Long COVID patients showed persistent immune activation and inflammatory responses for more than 180 days after initial infection, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways

  • Similar findings were confirmed in a second cohort from 2023-2024 with 18 long COVID patients and 20 controls, suggesting this inflammatory signature is consistent across different time periods

Why it matters: This provides concrete biological evidence that long COVID isn't just lingering symptoms—it's an ongoing inflammatory disease that persists months after the initial infection clears.

🥇 Top 1% journal 🔗 Nature immunology Journal Article 🗓️ Dec 13

Key Findings

🫀 Long COVID patients show autonomic dysfunction similar to pure autonomic failure

  • Researchers compared autonomic function in long COVID patients, healthy controls, and people with pure autonomic failure using heart rate and blood pressure tests

  • Long COVID patients had greater heart rate increases and blood pressure drops during standing tests compared to controls, plus lower respiratory sinus arrhythmia values

  • After adjusting for age and sex, autonomic dysfunction in long COVID patients was comparable to those with pure autonomic failure—and these abnormalities persisted up to 40 months after infection

💡 Long COVID may involve serious, long-lasting damage to the autonomic nervous system that controls basic bodily functions.
🥇 Top 1% journal 🔗 Journal of the American College of Cardiology Journal Article 🗓️ Dec 10

💊 Monoclonal antibody shows promise in three long COVID patients

  • Three patients with debilitating long COVID received pemivibart infusion (a monoclonal antibody normally used for COVID prevention in immunocompromised people)

  • All three experienced rapid improvement in fatigue, cognitive dysfunction, and dysautonomia—with one achieving resolution of limiting symptoms within a week

  • Benefits varied in duration from 2-3 weeks to sustained recovery at 6 weeks, suggesting the treatment may help clear persistent viral antigens

💡 Monoclonal antibodies designed to neutralize the virus might help some long COVID patients by clearing lingering viral remnants.
🔗 Cureus Case Reports 🗓️ Dec 8

🎯 Celiac plexus blocks successfully treat long COVID gut symptoms

  • Three patients with persistent post-COVID stomach pain and diarrhea received celiac plexus blocks—nerve blocks commonly used for abdominal pain

  • All patients experienced improvement in their gastrointestinal symptoms after the procedure

  • This is the first reported use of this technique for long COVID, suggesting the autonomic nervous system plays a role in persistent digestive problems

💡 Nerve blocks might offer relief for long COVID patients struggling with ongoing digestive issues.
Top 20% journal 🔗 Frontiers in neuroscience Case Reports 🗓️ Dec 8

🩸 Blood clotting markers elevated in long COVID patients

  • 75 COVID-19 patients were followed longitudinally and stratified by acute disease severity and long COVID status

  • Those who developed long COVID showed significantly elevated plasma Factor-IX, Tissue factor, and tPA between 1-35 days post-infection

  • Pathway analysis revealed ongoing neutrophil degranulation, platelet activation, and extracellular matrix remodeling persisting beyond 77 days post-symptom onset

💡 Persistent blood clotting abnormalities may explain some of the cardiovascular and circulatory symptoms in long COVID.
Top 20% journal 🔗 BMC infectious diseases Journal Article 🗓️ Dec 10

🧠 Long COVID patients' immune cells overreact to viral-like threats

  • Researchers exposed blood cells from long COVID patients and healthy controls to viral mimics that activate immune pathways

  • Long COVID patients' cells produced significantly more type I interferons (immune signaling molecules) when stimulated with both cGAS and RIG-I agonists

  • The interferon response correlated moderately with fatigue severity scores, suggesting this hyperresponsive immune state contributes to symptoms

💡 Long COVID patients may have immune cells that are stuck in an overactive state, responding too strongly to perceived threats.
🥉 Top 5% journal 🔗 Journal of Clinical Immunology Journal Article 🗓️ Dec 10

🏥 Healthcare workers show distinct long COVID symptom patterns by ethnicity and role

  • Among 4,033 healthcare workers with COVID history, 26.5% (1,067) developed long COVID symptoms lasting 12+ weeks

  • Asian healthcare workers had 62% higher odds of cardiopulmonary symptoms, while female workers were more likely to experience gastrointestinal and cognitive symptoms

  • Those in nursing, allied health, and dental roles reported significantly more musculoskeletal symptoms compared to medical professionals

💡 Long COVID symptoms vary significantly by ethnicity, gender, and job type, suggesting the need for targeted workplace support strategies.
🎖️ Top 10% journal 🔗 Journal of the Royal Society of Medicine Journal Article 🗓️ Dec 8

Implications

These studies reveal long COVID as a complex, multi-system disease involving persistent inflammation, autonomic dysfunction, and hyperactive immune responses that can last years after infection. The emerging treatment approaches—from nerve blocks to monoclonal antibodies—suggest that targeted interventions addressing specific biological pathways may offer hope for the millions affected by this condition.

Studies in this issue

Primary sources used for this newsletter.

  1. Long COVID involves increased inflammation and tired immune response
    main storyNature immunology2025-12-13PMID 41388153
  2. Stronger Immune Response in Blood Cells of Long COVID Patients After Exposure to Viral Signals
    key findingJournal of clinical immunology2025-12-10PMID 41372563
  3. Links Between Nervous System Problems and Long COVID Using Detailed Autonomic Tests
    key findingJournal of the American College of Cardiology2025-12-10PMID 41369621
  4. Pemivibart antibody treatment in long COVID: early clinical observations from a case series
    key findingCureus2025-12-08PMID 41357034
  5. Higher blood clotting markers and platelet activity linked to long-term COVID-19 symptoms
    key findingBMC infectious diseases2025-12-10PMID 41372813
  6. Long COVID symptom patterns in UK healthcare workers and how they vary by personal, health, and job factors
    key findingJournal of the Royal Society of Medicine2025-12-08PMID 41359411
  7. Celiac plexus block may improve digestive symptoms in Long COVID
    key findingFrontiers in neuroscience2025-12-08PMID 41357833

Continue reading

All Long Covid issues